Trade this ETF at your broker
Index | Solactive L&G Global Thematic |
Investment focus | Equity, World, Social/Environmental |
Fund size | EUR 4 m |
Total expense ratio | 0.60% p.a. |
Replication | Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 13.17% |
Inception/ Listing Date | 1 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Legal & General (LGIM) |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
Investment Advisor | Legal & General Investment Management Limited |
Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
Revision Company | EY |
Fiscal Year End | 30 June |
Swiss representative | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
Tax data | Bundesanzeiger | |
Germany | Unknown | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | BNY Mellon Fund Services (Ireland) Limited |
Securities lending | No |
Securities lending counterparty |
HD Hyundai Electric Co., Ltd. | 1.80% |
Sumitomo Electric Industries Ltd. | 1.32% |
Vertex Pharmaceuticals, Inc. | 0.97% |
Siemens Energy AG | 0.86% |
Swedish Orphan Biovitrum AB | 0.85% |
Tesla | 0.85% |
Renault SA | 0.84% |
Incyte Corp. | 0.73% |
United Therapeutics Corp. | 0.72% |
AstraZeneca PLC ADR | 0.71% |
Broker | Rating | Execution fee | Account fee | More information |
---|---|---|---|---|
![]() | free of charge | free of charge | View offer* | |
![]() | free of charge | free of charge | View offer* | |
![]() | free of charge | free of charge | View offer* | |
![]() | free of charge | free of charge | View offer* | |
![]() | EUR 1.50 1.50% | free of charge | View offer* |
YTD | +5.40% |
1 month | +2.73% |
3 months | +6.46% |
6 months | +7.01% |
1 year | +5.08% |
3 years | - |
5 years | - |
Since inception (MAX) | +5.40% |
2023 | +8.58% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 13.15% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.39 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -16.47% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -17.04% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | THNZ | - - | - - | - |
Borsa Italiana | EUR | THMZ | THMZ IM THNZEUIV | THMZ.MI | Flow Traders B.V. |
London Stock Exchange | GBX | THMG | THMG LN | THMG.L | Flow Traders B.V. |
London Stock Exchange | USD | THMZ | THMZ LN | THMZ.L | Flow Traders B.V. |
SIX Swiss Exchange | CHF | THMZ | THMZ SW THNZEUIV | THMZ.S | Flow Traders B.V. |
XETRA | EUR | THNZ | THNZ GY THNZEUIV | THNZ.DE | Flow Traders B.V. |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 1,022 | 0.40% p.a. | Accumulating | Sampling |
Amundi MSCI Disruptive Technology ESG Screened UCITS ETF Acc | 143 | 0.45% p.a. | Accumulating | Full replication |
WisdomTree Megatrends UCITS ETF USD | 49 | 0.50% p.a. | Accumulating | Full replication |
Xtrackers MSCI Innovation UCITS ETF 1C | 8 | 0.30% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 7 | 0.35% p.a. | Accumulating | Full replication |